Quarterly Result13 Aug 2025, 10:36 am
Mercury Laboratories Ltd Reports Q3 2025 Financial Results with 13.81% Net Profit Growth
AI Summary
Mercury Laboratories Ltd, a leading player in the pharmaceuticals industry, has reported its unaudited financial results for the quarter ended on June 30, 2025. The company's revenue from operations stands at INR 1,813.54 crores, representing a growth of 6.67% compared to the same period last year. The net profit for the quarter stands at INR 13.81 crores, marking a significant growth of 13.81% compared to the previous quarter. The company's earnings per share (EPS) for the quarter stood at INR 26.21. The company's financial results have been prepared in accordance with Indian Accounting Standards.
Key Highlights
- Revenue from operations for Q3 2025 stands at INR 1,813.54 crores, representing a growth of 6.67% YoY.
- Net profit for the quarter stands at INR 13.81 crores, marking a growth of 13.81% compared to the previous quarter.
- Earnings per share (EPS) for the quarter stood at INR 26.21.
- The company's financial results have been prepared in accordance with Indian Accounting Standards.
- The Statutory Auditors have performed a 'Limited Review' of the financial results for the quarter ended on June 30, 2025.